The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

A federal judge blocked President Donald Trump's effort to slash funding for National Institutes of Health research programs at universities and medical systems that threatened a key source of funding ...

While 22 states have sued the Trump Administration to temporarily block a major policy change by the National Institute of ...

The phase 2 CAFETERIA study included participants aged 4 to 14 years who were able to tolerate at least 143mg of peanut protein.

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

The findings are disappointing, but questions around intervention timing, patient population, and others remain to be ...